22-24439072-CTTTTTTTTTTTTTTTTTT-CTTTTT
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_000675.6(ADORA2A):c.333-1491_333-1482delTTTTTTTTTT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_000675.6 intron
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000675.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADORA2A | MANE Select | c.333-1491_333-1482delTTTTTTTTTT | intron | N/A | NP_000666.2 | ||||
| ADORA2A | c.333-1491_333-1482delTTTTTTTTTT | intron | N/A | NP_001265426.1 | P29274 | ||||
| ADORA2A | c.333-1491_333-1482delTTTTTTTTTT | intron | N/A | NP_001265427.1 | X5DNB4 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ADORA2A | TSL:1 MANE Select | c.333-1506_333-1497delTTTTTTTTTT | intron | N/A | ENSP00000336630.6 | P29274 | |||
| ADORA2A | TSL:1 | c.333-1506_333-1497delTTTTTTTTTT | intron | N/A | ENSP00000481552.1 | P29274 | |||
| SPECC1L-ADORA2A | TSL:2 | n.*1468-1506_*1468-1497delTTTTTTTTTT | intron | N/A | ENSP00000351480.2 | F8WAN1 |
Frequencies
GnomAD3 genomes Cov.: 25
GnomAD4 genome Cov.: 25
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.